𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients

✍ Scribed by Ravishankar Jayadevappa; Jerry C. Johnson; Sumedha Chhatre; Alan J. Wein; S. Bruce Malkowicz


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
110 KB
Volume
109
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND.

Ethnic variation in patient‐reported outcomes such as health‐related quality of life (HRQoL) and satisfaction with care are understudied areas in the management of elderly prostate cancer (PCa) patients.

METHODS.

In this prospective cohort study, between the years 2002 and 2004, the authors recruited 214 older (≥65 years) men with newly diagnosed PCa from an urban academic hospital and a Veterans Administration hospital. Participants completed generic (SF‐36), prostate‐specific (UCLA‐PCI) HRQoL, and satisfaction with care (CSQ‐8) surveys at baseline and at 3, 6, and 12‐months follow‐up. Clinically significant difference was used to compute return to baseline. The authors compared time to return to baseline HRQoL after controlling for confounding variables by using ANOVA and log‐linear models. Survival curves were used to compare time to return to baseline across ethnicity.

RESULTS.

Regression analysis revealed that age and marital status, not ethnicity, were independent predictors of radical prostatectomy, rather than radiation treatment. African Americans reported lower HRQoL scores at diagnosis and required a longer time to return to baseline. Log‐linear analysis indicated that African‐American ethnicity was associated with lower 12‐month scores for role physical (odds ratio [OR], 0.46; standard error [SE], 0.40), role emotional (OR, 0.37; SE, 0.43), bodily pain (OR, 0.74; SE, 0.10), urinary function (OR, 0.90; SE, 0.11), and urinary bother (OR, 0.72; SE, 0.17). Both groups reported comparably high levels of satisfaction with care.

CONCLUSIONS.

African‐American elderly exhibited poorer outcomes and required a longer time to return to baseline HRQoL. These differences highlight the need for discussion with patients and families prior to treatment about expectations and the need for support services post‐treatment. Cancer 2007. © 2007 American Cancer Society.


📜 SIMILAR VOLUMES


Clinical utility of apparent diffusion c
✍ Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

## Abstract ## Purpose To retrospectively evaluate the relationship between apparent diffusion coefficient (ADC) values and Gleason score (GS) in prostate cancer. ## Methods A total of 60 patients who underwent radical prostatectomy for clinically localized prostate cancer were selected for this

Response of plasma fibrinogen and plasmi
✍ U. S. Seal; R. P. Doe; D. P. Byar; D. K. Corle 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

Fibrinogen and plasminogen were measured in plasma samples from prostatic cancer patients before and after 3 months of treatment with either Premarin, Provera, Provera and diethylstilbestrol, one of three doses of diethylstilbestrol, o r placebo. Plasminogen levels generally were increased significa